Market Outlook
The global Implantable Drug Delivery Devices market size was valued at USD 482 million in 2022 and is forecast to a readjusted size of USD 677.1 million by 2029 with a CAGR of 5.0% during review period.
Implantable drug delivery devices are an alternative system that can achieve effective delivery with lower drug concentrations, and as a result, minimize side-effects whilst increasing patient compliance.
BD, B.Braun, AngioDynamics, Smiths Medical and Teleflex, etc. are the leading products in the international market, accounting for 85.5% of the global market.
This report is a detailed and comprehensive analysis for global Implantable Drug Delivery Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Implantable Drug Delivery Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Implantable Drug Delivery Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Implantable Drug Delivery Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Implantable Drug Delivery Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Implantable Drug Delivery Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Implantable Drug Delivery Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
BD
B.Braun
AngioDynamics
Smiths Medical
Teleflex
Cook Medical
Fresenius
Vygon
PFM Medical
Districlass
Linhwa
Segmentation By Type
Titanium Drug Delivery System
Plastic Drug Delivery System
Segmentation By Application
Intravenous Chemotherapy
Nutrition Support Therapy
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Implantable Drug Delivery Devices Market in 2025?
The strengths lie in the increasing adoption of personalized medicine and the growing demand for controlled drug release. Implantable devices offer precise dosage, improved patient compliance, and minimized side effects, making them highly attractive for chronic conditions.
What are the weaknesses of the Implantable Drug Delivery Devices Market in 2025?
A major weakness is the high cost of development and manufacturing, which can limit accessibility for some patient populations. Additionally, device-related complications like infection or device failure may deter patients from opting for these treatments.
What are the opportunities in the Implantable Drug Delivery Devices Market in 2025?
Opportunities include the rise in the prevalence of chronic diseases, such as diabetes and cancer, that require long-term medication. Technological advancements, like miniaturization and smarter delivery systems, present opportunities for growth and innovation in this market.
What are the threats to the Implantable Drug Delivery Devices Market in 2025?
Threats include stringent regulatory requirements, the potential for adverse events, and competition from alternative drug delivery systems, such as oral formulations or non-invasive options. Additionally, economic factors and healthcare budget constraints can impact market growth.
Market PESTEL Analysis
What are the political factors affecting the Implantable Drug Delivery Devices Market in 2025?
Political factors include the impact of healthcare policies, reimbursement regulations, and government support for medical innovations. Regulatory changes in drug approval processes and the availability of funding for medical technologies can influence market dynamics.
What are the economic factors affecting the Implantable Drug Delivery Devices Market in 2025?
Economic factors like healthcare budgets, reimbursement rates, and patient affordability play a crucial role. Economic instability or rising healthcare costs may limit access to implantable devices for certain patient groups, affecting market growth.
What are the social factors affecting the Implantable Drug Delivery Devices Market in 2025?
Social factors include an aging population, the growing awareness of chronic diseases, and the demand for more efficient, minimally invasive treatment options. Additionally, patient preferences for long-term, self-administered drug delivery systems are contributing to market growth.
What are the technological factors affecting the Implantable Drug Delivery Devices Market in 2025?
Technological advancements such as improved materials, miniaturization, and smart drug delivery systems are driving innovation in the market. These technologies enable better precision, ease of use, and patient monitoring, improving the overall efficacy of implantable devices.
What are the environmental factors affecting the Implantable Drug Delivery Devices Market in 2025?
Environmental factors include the growing emphasis on sustainable and eco-friendly materials in the manufacturing process. Companies are under pressure to reduce waste and minimize environmental impact, which could shape the design and production of implantable devices.
What are the legal factors affecting the Implantable Drug Delivery Devices Market in 2025?
Legal factors involve intellectual property rights, patent laws, and liability issues. Stringent regulations around device safety, effectiveness, and clinical trials must be followed to ensure compliance and market approval, impacting the speed of innovation.
Market SIPOC Analysis
Who are the suppliers in the Implantable Drug Delivery Devices Market in 2025?
Suppliers include manufacturers of raw materials such as polymers, metals, and bio-compatible materials, as well as suppliers of advanced technologies for device miniaturization and drug delivery systems. Research institutions and medical device component suppliers also play a key role.
What are the inputs required for the Implantable Drug Delivery Devices Market in 2025?
The inputs required include high-quality raw materials, technological innovations, research and development (R&D) for new drug delivery systems, regulatory approvals, and partnerships with healthcare providers to integrate these devices into treatment plans.
What are the processes involved in the Implantable Drug Delivery Devices Market in 2025?
Processes include product design and development, clinical trials for safety and efficacy, regulatory submissions, manufacturing and quality control, and marketing and distribution. Continuous monitoring and updates are also essential for product refinement and patient care.
Who are the customers in the Implantable Drug Delivery Devices Market in 2025?
Customers include healthcare providers such as hospitals, clinics, and specialized treatment centers, as well as patients requiring chronic disease management. Pharmaceutical companies that integrate these devices into their therapeutic offerings are also key customers.
What are the outputs of the Implantable Drug Delivery Devices Market in 2025?
The outputs are the implantable drug delivery devices themselves, which offer controlled and efficient drug release for chronic disease management, improving patient outcomes. These devices may also include accompanying patient support services, such as monitoring or education programs.
Market Porter's Five Forces
How strong is the threat of new entrants in the Implantable Drug Delivery Devices Market in 2025?
The threat of new entrants is moderate. High development costs, stringent regulatory approvals, and the need for advanced technological expertise create barriers to entry. However, innovations in technology and the growing demand for advanced medical devices may encourage new players.
How intense is the rivalry among existing competitors in the Implantable Drug Delivery Devices Market in 2025?
Rivalry among existing competitors is high. The market has well-established companies competing for market share, and innovation is a key driver. Companies are constantly improving their devices' features, efficacy, and safety to maintain a competitive edge.
How strong is the bargaining power of suppliers in the Implantable Drug Delivery Devices Market in 2025?
The bargaining power of suppliers is moderate. While some specialized materials and components are critical, there are multiple suppliers in the market. However, the need for high-quality, bio-compatible materials can give certain suppliers more leverage in negotiations.
How strong is the bargaining power of buyers in the Implantable Drug Delivery Devices Market in 2025?
The bargaining power of buyers is relatively low. Healthcare providers and patients have limited influence over pricing, especially given the specialized nature of implantable devices. However, as the market grows and more treatment options become available, buyers’ power may increase.
How high is the threat of substitutes in the Implantable Drug Delivery Devices Market in 2025?
The threat of substitutes is moderate. While implantable devices offer distinct advantages in controlled drug delivery, alternative drug delivery methods, such as oral medications and non-invasive treatments, could compete, especially as new technologies improve. However, the specific benefits of implantable devices make them harder to replace.
Market Upstream Analysis
What are the key suppliers involved in the upstream processes of the Implantable Drug Delivery Devices Market in 2025?
Key suppliers include raw material providers for bio-compatible polymers, metals, and advanced materials for miniaturization. Additionally, suppliers of specialized technology for device manufacturing, drug formulation, and smart delivery systems are critical.
What raw materials and components are essential in the upstream processes of the Implantable Drug Delivery Devices Market in 2025?
Essential raw materials include biocompatible polymers, metals, ceramics, and advanced electronics for smart drug delivery systems. High-quality materials that ensure device durability, safety, and patient compatibility are critical for the production of implantable devices.
What role does research and development play in the upstream processes of the Implantable Drug Delivery Devices Market in 2025?
R&D plays a pivotal role in developing innovative drug delivery systems, improving device performance, and ensuring safety. Continuous R&D is essential for designing smaller, more effective devices, as well as optimizing drug release mechanisms and patient monitoring systems.
What regulatory and compliance factors influence the upstream processes of the Implantable Drug Delivery Devices Market in 2025?
Regulatory compliance is a significant factor in upstream processes. Manufacturers must adhere to strict guidelines from regulatory bodies such as the FDA and EMA for device approval, clinical trials, and manufacturing standards. Compliance with safety and efficacy standards is critical to market access.
How does technological advancement affect the upstream processes of the Implantable Drug Delivery Devices Market in 2025?
Technological advancements drive innovation in upstream processes by improving the precision of drug delivery, enabling miniaturization of devices, and enhancing patient monitoring capabilities. The integration of smart technologies and materials science significantly influences the design and manufacturing processes.
Market Midstream Analysis
What are the key processes in the midstream of the Implantable Drug Delivery Devices Market in 2025?
The key processes include device manufacturing, quality control, regulatory testing, and clinical trials. Additionally, partnerships with healthcare providers and pharmaceutical companies for integration into treatment protocols are essential to ensure successful market adoption.
What role do manufacturers play in the midstream of the Implantable Drug Delivery Devices Market in 2025?
Manufacturers are responsible for the design, production, and assembly of implantable devices. They also oversee the testing of these devices for compliance with safety standards, ensuring they meet both medical and regulatory requirements for approval.
How does quality control impact the midstream of the Implantable Drug Delivery Devices Market in 2025?
Quality control ensures that devices are safe, reliable, and effective. This process involves rigorous testing of materials, device functionality, and long-term durability, which are critical to meeting regulatory standards and ensuring patient safety.
What is the significance of regulatory testing in the midstream of the Implantable Drug Delivery Devices Market in 2025?
Regulatory testing is crucial for gaining approval from health authorities such as the FDA or EMA. This process ensures that devices meet the required safety, efficacy, and performance standards before they can be marketed and distributed to healthcare providers.
How do partnerships and collaborations affect the midstream of the Implantable Drug Delivery Devices Market in 2025?
Partnerships with healthcare providers, pharmaceutical companies, and research institutions enhance the marketability of implantable devices. These collaborations can streamline the development process, aid in clinical trial design, and facilitate integration into existing therapeutic regimens.
Market Downstream Analysis
What are the key activities in the downstream processes of the Implantable Drug Delivery Devices Market in 2025?
Key activities include distribution to healthcare providers, patient education and training, post-market surveillance, and ongoing patient monitoring. Additionally, marketing and communication strategies to raise awareness among patients and healthcare professionals are important.
How do healthcare providers influence the downstream processes of the Implantable Drug Delivery Devices Market in 2025?
Healthcare providers play a vital role in prescribing and implanting these devices, ensuring that they are used correctly. They are also involved in patient follow-up, monitoring device performance, and assessing treatment outcomes, which contribute to the success of the devices in the market.
What role does patient adoption play in the downstream processes of the Implantable Drug Delivery Devices Market in 2025?
Patient adoption is critical to the downstream process. It requires patient trust in the safety and efficacy of the devices, as well as proper guidance on how to use them. Successful patient outcomes and satisfaction are key to the continued growth of this market.
How does post-market surveillance impact the downstream processes of the Implantable Drug Delivery Devices Market in 2025?
Post-market surveillance is essential for ensuring the long-term safety and efficacy of implantable devices. It involves tracking patient outcomes, monitoring for adverse events, and collecting feedback to improve future product iterations, ensuring regulatory compliance and enhancing market reputation.
How do distribution and supply chains affect the downstream processes of the Implantable Drug Delivery Devices Market in 2025?
Efficient distribution and supply chains are critical for ensuring timely delivery of devices to healthcare providers. Robust supply chains help maintain product availability, ensure quality control, and minimize disruptions, thereby supporting smooth implementation of these devices in clinical settings.
Chapter 1, to describe Implantable Drug Delivery Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Implantable Drug Delivery Devices, with price, sales, revenue and global market share of Implantable Drug Delivery Devices from 2018 to 2023.
Chapter 3, the Implantable Drug Delivery Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Implantable Drug Delivery Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Implantable Drug Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Implantable Drug Delivery Devices.
Chapter 14 and 15, to describe Implantable Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Implantable Drug Delivery Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Implantable Drug Delivery Devices Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Titanium Drug Delivery System
1.3.3 Plastic Drug Delivery System
1.4 Market Analysis by Application
1.4.1 Overview: Global Implantable Drug Delivery Devices Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Intravenous Chemotherapy
1.4.3 Nutrition Support Therapy
1.5 Global Implantable Drug Delivery Devices Market Size & Forecast
1.5.1 Global Implantable Drug Delivery Devices Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Implantable Drug Delivery Devices Sales Quantity (2018-2029)
1.5.3 Global Implantable Drug Delivery Devices Average Price (2018-2029)
2 Manufacturers Profiles
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Implantable Drug Delivery Devices Product and Services
2.1.4 BD Implantable Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 BD Recent Developments/Updates
2.2 B.Braun
2.2.1 B.Braun Details
2.2.2 B.Braun Major Business
2.2.3 B.Braun Implantable Drug Delivery Devices Product and Services
2.2.4 B.Braun Implantable Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 B.Braun Recent Developments/Updates
2.3 AngioDynamics
2.3.1 AngioDynamics Details
2.3.2 AngioDynamics Major Business
2.3.3 AngioDynamics Implantable Drug Delivery Devices Product and Services
2.3.4 AngioDynamics Implantable Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AngioDynamics Recent Developments/Updates
2.4 Smiths Medical
2.4.1 Smiths Medical Details
2.4.2 Smiths Medical Major Business
2.4.3 Smiths Medical Implantable Drug Delivery Devices Product and Services
2.4.4 Smiths Medical Implantable Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Smiths Medical Recent Developments/Updates
2.5 Teleflex
2.5.1 Teleflex Details
2.5.2 Teleflex Major Business
2.5.3 Teleflex Implantable Drug Delivery Devices Product and Services
2.5.4 Teleflex Implantable Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Teleflex Recent Developments/Updates
2.6 Cook Medical
2.6.1 Cook Medical Details
2.6.2 Cook Medical Major Business
2.6.3 Cook Medical Implantable Drug Delivery Devices Product and Services
2.6.4 Cook Medical Implantable Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cook Medical Recent Developments/Updates
2.7 Fresenius
2.7.1 Fresenius Details
2.7.2 Fresenius Major Business
2.7.3 Fresenius Implantable Drug Delivery Devices Product and Services
2.7.4 Fresenius Implantable Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Fresenius Recent Developments/Updates
2.8 Vygon
2.8.1 Vygon Details
2.8.2 Vygon Major Business
2.8.3 Vygon Implantable Drug Delivery Devices Product and Services
2.8.4 Vygon Implantable Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Vygon Recent Developments/Updates
2.9 PFM Medical
2.9.1 PFM Medical Details
2.9.2 PFM Medical Major Business
2.9.3 PFM Medical Implantable Drug Delivery Devices Product and Services
2.9.4 PFM Medical Implantable Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 PFM Medical Recent Developments/Updates
2.10 Districlass
2.10.1 Districlass Details
2.10.2 Districlass Major Business
2.10.3 Districlass Implantable Drug Delivery Devices Product and Services
2.10.4 Districlass Implantable Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Districlass Recent Developments/Updates
2.11 Linhwa
2.11.1 Linhwa Details
2.11.2 Linhwa Major Business
2.11.3 Linhwa Implantable Drug Delivery Devices Product and Services
2.11.4 Linhwa Implantable Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Linhwa Recent Developments/Updates
3 Competitive Environment: Implantable Drug Delivery Devices by Manufacturer
3.1 Global Implantable Drug Delivery Devices Sales Quantity by Manufacturer (2018-2023)
3.2 Global Implantable Drug Delivery Devices Revenue by Manufacturer (2018-2023)
3.3 Global Implantable Drug Delivery Devices Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Implantable Drug Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Implantable Drug Delivery Devices Manufacturer Market Share in 2022
3.4.2 Top 6 Implantable Drug Delivery Devices Manufacturer Market Share in 2022
3.5 Implantable Drug Delivery Devices Market: Overall Company Footprint Analysis
3.5.1 Implantable Drug Delivery Devices Market: Region Footprint
3.5.2 Implantable Drug Delivery Devices Market: Company Product Type Footprint
3.5.3 Implantable Drug Delivery Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Implantable Drug Delivery Devices Market Size by Region
4.1.1 Global Implantable Drug Delivery Devices Sales Quantity by Region (2018-2029)
4.1.2 Global Implantable Drug Delivery Devices Consumption Value by Region (2018-2029)
4.1.3 Global Implantable Drug Delivery Devices Average Price by Region (2018-2029)
4.2 North America Implantable Drug Delivery Devices Consumption Value (2018-2029)
4.3 Europe Implantable Drug Delivery Devices Consumption Value (2018-2029)
4.4 Asia-Pacific Implantable Drug Delivery Devices Consumption Value (2018-2029)
4.5 South America Implantable Drug Delivery Devices Consumption Value (2018-2029)
4.6 Middle East and Africa Implantable Drug Delivery Devices Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Implantable Drug Delivery Devices Sales Quantity by Type (2018-2029)
5.2 Global Implantable Drug Delivery Devices Consumption Value by Type (2018-2029)
5.3 Global Implantable Drug Delivery Devices Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Implantable Drug Delivery Devices Sales Quantity by Application (2018-2029)
6.2 Global Implantable Drug Delivery Devices Consumption Value by Application (2018-2029)
6.3 Global Implantable Drug Delivery Devices Average Price by Application (2018-2029)
7 North America
7.1 North America Implantable Drug Delivery Devices Sales Quantity by Type (2018-2029)
7.2 North America Implantable Drug Delivery Devices Sales Quantity by Application (2018-2029)
7.3 North America Implantable Drug Delivery Devices Market Size by Country
7.3.1 North America Implantable Drug Delivery Devices Sales Quantity by Country (2018-2029)
7.3.2 North America Implantable Drug Delivery Devices Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Implantable Drug Delivery Devices Sales Quantity by Type (2018-2029)
8.2 Europe Implantable Drug Delivery Devices Sales Quantity by Application (2018-2029)
8.3 Europe Implantable Drug Delivery Devices Market Size by Country
8.3.1 Europe Implantable Drug Delivery Devices Sales Quantity by Country (2018-2029)
8.3.2 Europe Implantable Drug Delivery Devices Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Implantable Drug Delivery Devices Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Implantable Drug Delivery Devices Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Implantable Drug Delivery Devices Market Size by Region
9.3.1 Asia-Pacific Implantable Drug Delivery Devices Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Implantable Drug Delivery Devices Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Implantable Drug Delivery Devices Sales Quantity by Type (2018-2029)
10.2 South America Implantable Drug Delivery Devices Sales Quantity by Application (2018-2029)
10.3 South America Implantable Drug Delivery Devices Market Size by Country
10.3.1 South America Implantable Drug Delivery Devices Sales Quantity by Country (2018-2029)
10.3.2 South America Implantable Drug Delivery Devices Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Implantable Drug Delivery Devices Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Implantable Drug Delivery Devices Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Implantable Drug Delivery Devices Market Size by Country
11.3.1 Middle East & Africa Implantable Drug Delivery Devices Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Implantable Drug Delivery Devices Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Implantable Drug Delivery Devices Market Drivers
12.2 Implantable Drug Delivery Devices Market Restraints
12.3 Implantable Drug Delivery Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Implantable Drug Delivery Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Implantable Drug Delivery Devices
13.3 Implantable Drug Delivery Devices Production Process
13.4 Implantable Drug Delivery Devices Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Implantable Drug Delivery Devices Typical Distributors
14.3 Implantable Drug Delivery Devices Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Implantable Drug Delivery Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Implantable Drug Delivery Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. BD Basic Information, Manufacturing Base and Competitors
Table 4. BD Major Business
Table 5. BD Implantable Drug Delivery Devices Product and Services
Table 6. BD Implantable Drug Delivery Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. BD Recent Developments/Updates
Table 8. B.Braun Basic Information, Manufacturing Base and Competitors
Table 9. B.Braun Major Business
Table 10. B.Braun Implantable Drug Delivery Devices Product and Services
Table 11. B.Braun Implantable Drug Delivery Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. B.Braun Recent Developments/Updates
Table 13. AngioDynamics Basic Information, Manufacturing Base and Competitors
Table 14. AngioDynamics Major Business
Table 15. AngioDynamics Implantable Drug Delivery Devices Product and Services
Table 16. AngioDynamics Implantable Drug Delivery Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. AngioDynamics Recent Developments/Updates
Table 18. Smiths Medical Basic Information, Manufacturing Base and Competitors
Table 19. Smiths Medical Major Business
Table 20. Smiths Medical Implantable Drug Delivery Devices Product and Services
Table 21. Smiths Medical Implantable Drug Delivery Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Smiths Medical Recent Developments/Updates
Table 23. Teleflex Basic Information, Manufacturing Base and Competitors
Table 24. Teleflex Major Business
Table 25. Teleflex Implantable Drug Delivery Devices Product and Services
Table 26. Teleflex Implantable Drug Delivery Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Teleflex Recent Developments/Updates
Table 28. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 29. Cook Medical Major Business
Table 30. Cook Medical Implantable Drug Delivery Devices Product and Services
Table 31. Cook Medical Implantable Drug Delivery Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Cook Medical Recent Developments/Updates
Table 33. Fresenius Basic Information, Manufacturing Base and Competitors
Table 34. Fresenius Major Business
Table 35. Fresenius Implantable Drug Delivery Devices Product and Services
Table 36. Fresenius Implantable Drug Delivery Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Fresenius Recent Developments/Updates
Table 38. Vygon Basic Information, Manufacturing Base and Competitors
Table 39. Vygon Major Business
Table 40. Vygon Implantable Drug Delivery Devices Product and Services
Table 41. Vygon Implantable Drug Delivery Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Vygon Recent Developments/Updates
Table 43. PFM Medical Basic Information, Manufacturing Base and Competitors
Table 44. PFM Medical Major Business
Table 45. PFM Medical Implantable Drug Delivery Devices Product and Services
Table 46. PFM Medical Implantable Drug Delivery Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. PFM Medical Recent Developments/Updates
Table 48. Districlass Basic Information, Manufacturing Base and Competitors
Table 49. Districlass Major Business
Table 50. Districlass Implantable Drug Delivery Devices Product and Services
Table 51. Districlass Implantable Drug Delivery Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Districlass Recent Developments/Updates
Table 53. Linhwa Basic Information, Manufacturing Base and Competitors
Table 54. Linhwa Major Business
Table 55. Linhwa Implantable Drug Delivery Devices Product and Services
Table 56. Linhwa Implantable Drug Delivery Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Linhwa Recent Developments/Updates
Table 58. Global Implantable Drug Delivery Devices Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Implantable Drug Delivery Devices Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Implantable Drug Delivery Devices Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Implantable Drug Delivery Devices, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Implantable Drug Delivery Devices Production Site of Key Manufacturer
Table 63. Implantable Drug Delivery Devices Market: Company Product Type Footprint
Table 64. Implantable Drug Delivery Devices Market: Company Product Application Footprint
Table 65. Implantable Drug Delivery Devices New Market Entrants and Barriers to Market Entry
Table 66. Implantable Drug Delivery Devices Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Implantable Drug Delivery Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Implantable Drug Delivery Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Implantable Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Implantable Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Implantable Drug Delivery Devices Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Implantable Drug Delivery Devices Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Implantable Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Implantable Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Implantable Drug Delivery Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Implantable Drug Delivery Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Implantable Drug Delivery Devices Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Implantable Drug Delivery Devices Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Implantable Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Implantable Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Implantable Drug Delivery Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Implantable Drug Delivery Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Implantable Drug Delivery Devices Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Implantable Drug Delivery Devices Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Implantable Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Implantable Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Implantable Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Implantable Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Implantable Drug Delivery Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Implantable Drug Delivery Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Implantable Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Implantable Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Implantable Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Implantable Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Implantable Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Implantable Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Implantable Drug Delivery Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Implantable Drug Delivery Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Implantable Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Implantable Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Implantable Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Implantable Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Implantable Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Implantable Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Implantable Drug Delivery Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Implantable Drug Delivery Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Implantable Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Implantable Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Implantable Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Implantable Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Implantable Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Implantable Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Implantable Drug Delivery Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Implantable Drug Delivery Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Implantable Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Implantable Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Implantable Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Implantable Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Implantable Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Implantable Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Implantable Drug Delivery Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Implantable Drug Delivery Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Implantable Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Implantable Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Implantable Drug Delivery Devices Raw Material
Table 126. Key Manufacturers of Implantable Drug Delivery Devices Raw Materials
Table 127. Implantable Drug Delivery Devices Typical Distributors
Table 128. Implantable Drug Delivery Devices Typical Customers
List of Figures
Figure 1. Implantable Drug Delivery Devices Picture
Figure 2. Global Implantable Drug Delivery Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Implantable Drug Delivery Devices Consumption Value Market Share by Type in 2022
Figure 4. Titanium Drug Delivery System Examples
Figure 5. Plastic Drug Delivery System Examples
Figure 6. Global Implantable Drug Delivery Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Implantable Drug Delivery Devices Consumption Value Market Share by Application in 2022
Figure 8. Intravenous Chemotherapy Examples
Figure 9. Nutrition Support Therapy Examples
Figure 10. Global Implantable Drug Delivery Devices Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Implantable Drug Delivery Devices Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Implantable Drug Delivery Devices Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Implantable Drug Delivery Devices Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Implantable Drug Delivery Devices Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Implantable Drug Delivery Devices Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Implantable Drug Delivery Devices by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Implantable Drug Delivery Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Implantable Drug Delivery Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Implantable Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Implantable Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Implantable Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Implantable Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Implantable Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Implantable Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Implantable Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Implantable Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Implantable Drug Delivery Devices Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Implantable Drug Delivery Devices Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Implantable Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Implantable Drug Delivery Devices Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Implantable Drug Delivery Devices Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Implantable Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Implantable Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Implantable Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Implantable Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Implantable Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Implantable Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Implantable Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Implantable Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Implantable Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Implantable Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Implantable Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Implantable Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
Figure 52. China Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Implantable Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Implantable Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Implantable Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Implantable Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Implantable Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Implantable Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Implantable Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Implantable Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Implantable Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Implantable Drug Delivery Devices Market Drivers
Figure 73. Implantable Drug Delivery Devices Market Restraints
Figure 74. Implantable Drug Delivery Devices Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Implantable Drug Delivery Devices in 2022
Figure 77. Manufacturing Process Analysis of Implantable Drug Delivery Devices
Figure 78. Implantable Drug Delivery Devices Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
